Rohrer Aesthetics launches FDA-cleared ReLumina dual-technology platform

Rohrer Aesthetics has introduced ReLumina, an FDA-cleared IPL and hair removal device aimed at medical aesthetics practices. The platform is available now, with an introductory purchase price of $49,995 and a rent-to-own option starting at $10,000 upfront.

Why it matters: - ReLumina gives aesthetic practices one platform for multiple treatments, including permanent hair reduction, skin pigmentation, and benign vascular lesions. - Rohrer Aesthetics is positioning the device as a lower-cost option for practices that want to expand services without buying separate systems.

What happened: - Rohrer Aesthetics announced ReLumina™, an FDA-cleared intense pulsed light and hair removal platform. - The device is available for order immediately through Rohrer Aesthetics. - The launch took place in Homewood, Alabama. - Rohrer Aesthetics says ReLumina is designed to combine clinical versatility with affordability.

The details: - ReLumina includes two dedicated, contact-cooled handpieces. - The device uses an indication-guided setup designed for Fitzpatrick skin types I through VI. - Rohrer Aesthetics says the interface gives staff a clear starting point for each procedure and is intended to support consistent treatment outcomes. - The platform is FDA-cleared for four categories of treatment: permanent hair reduction, benign pigmented lesions, benign vascular lesions and cutaneous lesions including scars. - The system is priced at $49,995 for outright purchase. - The Rohrer Advantage Program offers a rent-to-own path with a $10,000 upfront payment. - The program includes installation and hands-on training. - Monthly rental payments are $1,000. - Rohrer Aesthetics says no credit checks are required. - More information is available on Rohrer Aesthetics' website.

Between the lines: - The launch is aimed at practices that want a broader treatment menu and a lower barrier to entry. - Rohrer Aesthetics is using price and financing as a major selling point, not just device capabilities. - The company is trying to appeal to both established practices and newer buyers that may prefer predictable monthly payments.

What's next: - Practices can begin ordering ReLumina now. - Rohrer Aesthetics is also offering product demonstrations for prospective buyers. - The company is likely to market the platform around treatment versatility, patient comfort and practice ROI.

The bottom line: - ReLumina is Rohrer Aesthetics' pitch for an all-in-one, FDA-cleared aesthetics platform at a sub-$50,000 price point.